| Literature DB >> 30854321 |
Cesar Y Guerrero-Miranda1,2,3, Shelley A Hall1,2,3.
Abstract
Extracorporeal membrane oxygenation (ECMO) is used to support critically ill patients when conventional therapies have failed. ECMO has been available for four decades and has gained use as a rescue therapy in severe refractory hypoxic disorders and in patients with refractory cardiogenic shock (RCS). Over recent years, several percutaneous cardiac interventions and implant devices have been developed that are now used frequently in conjunction with ECMO in order to maintain organ perfusion. Here, we review the literature on VA-ECMO cannulation location, the use of VA-ECMO in interventions (e.g., coronary interventions and structural heart interventions) and percutaneous cardiac device implantation in VA-ECMO recipients with RCS.Entities:
Keywords: Extracorporeal membrane oxygenation (ECMO); cardiac catheterization; cardiogenic shock; heart failure (HF); percutaneous devices
Year: 2019 PMID: 30854321 PMCID: PMC6379180 DOI: 10.21037/acs.2018.11.08
Source DB: PubMed Journal: Ann Cardiothorac Surg ISSN: 2225-319X